Resource Library

Whitepapers

Monoclonal Antibody Manufacturing: Build Or Outsource?

Monoclonal_antibody_manufacturing-_Build_or_outsource_.png.png

A company's strategy significantly shapes its future success, and therefore it needs to be carefully considered and evolved in line with market dynamics. Although building in-house can offer the advantage of direct control, the time, labor, and spend required to implement this often makes it an inefficient choice. Working with an innovative, strategic, and experienced contract manufacturer can help you make better use of valuable internal resources, leverage a deep pool of industry experience, and help you mitigate risk across development cycles, keeping you competitive in a rapidly evolving market. Of course, the process of selecting the right CDMO partner needs to be performed after careful analysis of many factors. Speed to market, efficiency at scale, and operational knowledge bases are critical factors developers must consider when deciding to manufacture mAbs internally or through a contract manufacturer. This article provides the key parameters to consider to make better decisions for your future manufacturing strategy.

Monoclonal_antibody_manufacturing-_Build_or_outsource_.png.png

A company's strategy significantly shapes its future success, and therefore it needs to be carefully considered and evolved in line with market dynamics. Although building in-house can offer the advantage of direct control, the time, labor, and spend required to implement this often makes it an inefficient choice. Working with an innovative, strategic, and experienced contract manufacturer can help you make better use of valuable internal resources, leverage a deep pool of industry experience, and help you mitigate risk across development cycles, keeping you competitive in a rapidly evolving market. Of course, the process of selecting the right CDMO partner needs to be performed after careful analysis of many factors. Speed to market, efficiency at scale, and operational knowledge bases are critical factors developers must consider when deciding to manufacture mAbs internally or through a contract manufacturer. This article provides the key parameters to consider to make better decisions for your future manufacturing strategy. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION